Рет қаралды 3,378
Video property of Otsuka and Lundbeck. Dr Stephen Stahl presents the pharmacological profile of Rexulti (Brexpiprazole), an atypical antipsychotic approved for the treatment of schizophrenia and as an adjunct therapy in the treatment of major depressive disorder.